Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers

Summary

This study will be a randomised, open-label, 3-period, 3-treatment, single-dose, crossover study in healthy subjects The study will be performed at a single study centre in the United Kingdom.

Timeline

Start

2021-02-01

Primary completion

2021-03-25

Completion

2021-03-25

Drugs

Indications